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DObjective: To compare the long-term echocardiographic mitral valve (MV) durability after MV repair
performed through a minithoracotomy versus conventional sternotomy.
Methods: A total of 299 patients who underwent MV repair for degenerative mitral regurgitation (MR) through
minithoracotomy (n¼ 179) or sternotomy (n¼ 120), between April 2004 and January 2010, were evaluated. To
adjust the differences in baseline characteristics between the 2 groups, weighted Cox proportional-hazards
regression models and inverse-probability-of-treatment weighting were used.
Results: There were no 30-day deaths in both groups and no significant differences in early complication rates.
Clinical follow-up was complete in 294 patients (98.3%), with a median follow-up of 55.4 months (interquartile
range, 34.4-66.9 months), during which there were 10 late deaths, 2 strokes, and 3 reoperations for recurrentMR.
After adjustment, the minithoracotomy group had similar risks for major adverse cardiac events (hazard ratio,
0.77; 95% confidence interval, 0.22-2.68; P¼ .68). Echocardiographic evaluation in the late period (>6months)
was possible in 292 patients (97.7%), with a median follow-up of 29.4 months (interquartile range, 13.3-49.7
months), during which 21 patients (12 in the minithoracotomy group and 9 in the sternotomy group) experienced
significant MR (>2þ). Freedom from significant MR at 5 years was 86.1%  4.8% versus 85.3%  5.5%
(P ¼ .63). After adjustment, the minithoracotomy group had similar risks for significant MR (hazard ratio,
0.81; 95% confidence interval, 0.31-2.14; P ¼ .67).
Conclusions:Aminithoracotomy approach for MV repair showed comparable clinical outcomes and efficacy to
conventional sternotomy for MV repair. (J Thorac Cardiovasc Surg 2014;147:1547-52)Minimally invasive cardiac surgery (MICS) techniques for
mitral valve (MV) repair have advanced during the past de-
cade, and favorable results have been reported. Several single
institutional studies have shown excellent clinical outcomes
of the MICS approach, such as comparable short- and long-
term mortality/morbidity, reduced sternal complications,
and shortening of duration of ventilation and intensive care
unit (ICU) and hospital stays.1-5 A recent consensus
statement of the International Society of Minimally
Invasive Surgery 2010 also documented that MICS enables
complex valve surgery to be performed, with results
equivalent to those of conventional valve surgery in
experienced centers6; a systemic review of the literature
with a meta-analysis of all important series has been pub-
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ersity of Ulsan, College of Medicine, Seoul, South Korea.
ures: Authors have nothing to disclose with regard to commercial support.
d for publication March 13, 2013; revisions received April 24, 2013; accepted
blication May 10, 2013; available ahead of print July 15, 2013.
for reprints: JaeWon Lee, MD, PhD, Department of Thoracic and Cardiovas-
Surgery, Asan Medical Center, University of Ulsan, College of Medicine, 88
pic-ro 43-gil, Songpa-gu, Seoul 138-736, South Korea (E-mail: jwlee@amc.
.kr).
23/$36.00
Copyright  2014 Published by Elsevier Inc. on behalf of The American
tion for Thoracic Surgery
.doi.org/10.1016/j.jtcvs.2013.05.042
The Journal of Thoracic and Carthe long-term efficacy of MV repair performed with MICS
techniques. Although there have been several reports focused
on comparing the long-term freedom from reoperation be-
tween MICS and sternotomy, few studies demonstrated the
long-term quality of the repairedMV (regurgitation or steno-
sis) and freedom fromsignificantMRbasedon long-term reg-
ular echocardiographic follow-up.8-10 In addition, previous
studies have limitations for comparing outcomes between
2 groups, with significant differences in baseline
characteristics. We, therefore, sought to compare the long-
term clinical and echocardiographic outcomes of MV
repair performed through a minithoracotomy versus a tradi-
tional sternotomy in a homogeneous population with degen-
erativeMR using inverse-probability-of-treatment weighting
(IPTW) to reduce baseline differences.METHODS
Study Population
From April 2004 to January 2010, a total of 544 patients underwent MV
repair for degenerative MR at Asan Medical Center (Seoul, Korea). Pa-
tients with combined aortic valve diseases, coronary diseases, and aortic
diseases were excluded. Patients who underwent previous cardiac surgery
were also excluded. However, patients with combined tricuspid regurgita-
tion or atrial fibrillation (AF) were not excluded. Finally, a total of 299 pa-
tients who underwent MV repair for degenerative MR, with or without
concomitant tricuspid annuloplasty or AF ablation, were identified anddiovascular Surgery c Volume 147, Number 5 1547
Abbreviations and Acronyms
AF ¼ atrial fibrillation
ICU ¼ intensive care unit
IPTW ¼ inverse-probability-of-treatment weighting
LA ¼ left atrial
MICS ¼ minimally invasive cardiac surgery
MR ¼ mitral regurgitation
MV ¼ mitral valve
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Dwere divided into 2 groups, a minithoracotomy group (n¼ 179) and a ster-
notomy group (n ¼ 120). A video-assisted MICS technique for MR had
been performed by a single surgeon (J.W.L.) for patients with degenerative
MR in the absence of risk factors for theMICS approach, such as peripheral
arterial obstructive disease or a severely tortuous abdominal aorta, difficult
chest wall shape for port access surgery (eg, funnel chest), or difficulty in
single-lung ventilation as the result of poor lung function. In addition, if
a patient had preoperative AF with the high risk factors for ablation failure,
such as giant left atrial (LA) size, low ejection fraction, or long-standing
persistent AF with a fine wave, a median sternotomy approach was favored
to routinely obliterate or resect LA auricle to prevent thromboembolism.
The decision between MICS and conventional sternotomy depended pri-
marily on the patient’s condition and the patient’s preference, based on
the informed consent. We retrospectively reviewed patients’ preoperative
characteristics and early and late clinical and echocardiographic outcomes.
This study was approved by our institutional Ethics Committee/Review
Board (Institutional Review Board No. 2011-0981), which waived the re-
quirement for informed patient consent because of the retrospective nature
of this study.
Surgical Procedures
The sternotomy approach used conventional ascending aorta and bi-
caval cannulation, whereas the minithoracotomy involved peripheral can-
nulation through the right internal jugular vein and right femoral artery and
vein. In the minithoracotomy approach, a 4- or 5-cm horizontal incision
was made over the fourth intercostal space between the anterior and me-
dian axillary lines and a thoracoscope was inserted through a 1-cm port
at the third right intercostal space on the median axillary line (Figure 1).
Details of these procedures have previously been described.11 Myocardial
protection during conventional sternotomy was achieved with antegrade
and retrograde tepid blood cardioplegia and during the minithoracotomy
approach with antegrade cold crystalloid cardioplegia. After cardioplegic
arrest and aortic crossclamping, the MVwas exposed through an interatrial
groove. Concomitant maze procedures were performed in 83 patients
(27.8%), for whom amodification of the maze procedurewas performed.12
Echocardiographic Evaluation
All patients underwent 2-dimensional echocardiographic analysis and
Doppler color-flow imaging using a Hewlett-Packard Sonos 2500 or 5500
imaging system equipped with a 2.5-MHz transducer (Hewlett-Packard,
Andover, Mass) within 2 months before the operation. Preoperative transe-
sophageal echocardiographywas also performed formore accurate analysis
of MV morphology. MR was detected and semiquantitatively graded as
trace, mild, moderate, or severe using color Doppler flow imaging.13
Follow-up
Data were obtained until July 2011 during biannual visits to the outpa-
tient clinic. Early mortalitywas defined as death within 30 days of surgery.
Data on vital status, dates of death, and causes of death were obtained from
the Korean national registry of vital statistics.Major adverse cardiac event
was defined as all-cause death or valve-related complication, the latter of1548 The Journal of Thoracic and Cardiovascular Surwhich included thromboembolism, reoperation, infective endocarditis, or
warfarin-related hemorrhage.
Statistical Analysis
Categorical variables were presented as frequencies and percentages,
and continuous variables were expressed as mean  SD or medians with
ranges. Differences in baseline characteristics between patients in the
minithoracotomy group and those in the sternotomy group were compared
using the t-test or theMann-WhitneyU test for continuous variables and the
c2 test or Fisher exact test for categorical variables, as appropriate. To
reduce the impact of treatment selection bias and potential confounding
in an observational study, we performed rigorous adjustment for significant
differences in patient characteristics by using Cox proportional-hazards re-
gression models and IPTW.14-16 With this technique, weights for patients
undergoing MV repair through a minithoracotomy were the inverse of
propensity score, and weights for patients with conventional sternotomy
were the inverse of 1 – propensity score. Stabilized weights were used to
reduce the weights of either those treated subjects with low propensity
scores or those untreated subjects with high propensity scores.17 The pro-
pensity scores were estimated by multiple logistic regression analysis.14
All prespecified covariates were included in full nonparsimonious models
for the minithoracotomy group versus the sternotomy group (Table 1). The
discrimination and calibration abilities of each propensity score model
were assessed by C statistics and the Hosmer-Lemeshow test. The model
was well calibrated (Hosmer-Lemeshow test, P ¼ .12) with reasonable
discrimination (C statistic, 0.73). Results were expressed as hazard ratio
(HR) with 95% confidence intervals. All reported P values are 2 sided,
and values of P<.05 were considered to indicate statistical significance.
All statistical analyses were performed using SPSS, version 18.0 (IBM,
Armonk, NY) and R, version 2.15.1 (http://www.r-project.org).RESULTS
Baseline Characteristics and Operative Data
Baseline characteristics of the patients are shown in
Table 1. Before adjustment, the proportions of preoperative
New York Heart Association classification III/IV, AF, and
significant tricuspid regurgitation were higher in the
sternotomy group. Preoperative LA dimension and esti-
mated pulmonary artery systolic pressure (tricuspid valve
pressure gradient) were also higher in the sternotomy group.
After adjustment with the use of IPTW, the significant
differences in baseline characteristics between the 2 groups
were well balanced (Table 1).
The cardiopulmonary bypass time was 131.7  38.5
minutes in the minithoracotomy group and 126.6  43.2
minutes in the sternotomy group (P ¼ .30), and the aortic
crossclamp times were 84.3  28.7 and 80.5  32.0 min-
utes, respectively (P ¼ .39). Concomitant maze procedures
were conducted in 24.6% of patients in the minithoracot-
omy group and in 32.5% of patients in the sternotomy
group (P¼ .15). Except for the performance of concomitant
tricuspid annuloplasty, other operative variables were not
significantly different (Table 2).Clinical Outcomes
There were no early deaths in either group and no differ-
ences in immediate postoperative complications (Table 3).
The lengths of hospital stay and ICU stay of thegery c May 2014
FIGURE 1. A 4- to 5-cm right inframmammary skin incision and right
fourth intercostal space minithoracotomy in a female patient and other sites
for thoracoscopy. The chitwood clamp and left atrial vent are shown. ICS,
Intercostal space; LA, left atrial.
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those of the sternotomy group (P ¼ .039 and P ¼ .012,








Male sex 111 (62.0) 79 (65.8)
Age, y 48.9  14.1 56.6  13.2
Body surface area, m2 1.7  0.2 1.7  0.2
Clinical data
NYHA Fc III or IV 39 (21.8) 60 (50)
Atrial fibrillation 45 (25.2) 46 (32.5)
Hypertension 57 (31.8) 48 (40)
Diabetes mellitus 8 (4.5) 12 (10)
History of stroke 1 (0.6) 3 (2.5)
Echocardiographic data
LV ejection fraction,% 61.6  7.3 61.5  8.5
LV systolic dimension, mm 38.8  6.4 39.9  7.9
LV diastolic dimension, mm 60.8  6.7 62.1  7.7
LA dimension, mm 49.9  8.9 55.0  11.8
TR grade (>2þ) 13 (7.3) 25 (20.8)
TV pressure gradient, mmHg 33.8  15.8 40.0  17.2
MR grade
Severe 168 (93.9) 114 (95)
Moderate to severe 11 (6.1) 6 (5)
MV leaflet prolapse subsets
Anterior leaflet 30 (16.8) 16 (13.3)
Bileaflet 30 (16.8) 37 (30.8)
Posterior leaflet 119 (66.5) 67 (55.8)
IPTW, Inverse-probability-of-treatment weighting; NYHA Fc, New York Heart Associat
TV, tricuspid valve; MR, mitral regurgitation; MV, mitral valve. *Value are given as numb
The Journal of Thoracic and CarClinical follow-up was complete in 294 patients
(98.3%), with a median follow-up of 55.4 months
(interquartile range, 34.4-66.9 months), during which
there were 10 late deaths, 2 cases of stroke, and 3 cases
of reoperation. Two cases of reoperation were due to
recurrent MR, and the other one was due to dilated
cardiomyopathy. There was no mitral stenosis. Major
event-free survival at 5 years was 97.6%  1.2% in
the minithoracotomy group and 87.5%  4.9% in the
sternotomy group (P ¼ .046) (Figure 2, left). However,
after adjustment with weighted Cox regression analysis,
both groups had comparable event-free survival (HR,
0.77; 95% confidence interval, 0.22-2.68; P ¼ .68)
(Figure 2, right).Echocardiographic Outcomes
Echocardiographic evaluation was possible in 292
patients (97.7%), with a median follow-up of 29.4 months
(interquartile range, 13.3-49.7 months), during which 21
patients (12 in the minithoracotomy group and 9 in the
sternotomy group; P ¼ .72) experienced significant MR
(>2þ). Freedom from significant MR (>2þ) at 5 years
was 86.1% 4.8% versus 85.3% 5.5% in the minithor-





(n ¼ 120) P value
.50 62.0 65.8 .50
.14 51.8  13.7 52.1  14.8 .84
.45 1.7  0.2 1.7  0.2 .22
<.001 34.5 37.2 .12
.021 29.1 29.2 .98
.15 36.3 35.0 .82
.061 6.7 6.7 .99
.15 1.7 1.7 .99
.95 61.8  7.2 61.7  7.8 .89
.48 37.7  6.7 39.0  7.4 .76
.50 60.8  7.3 61.2  7.5 .62
.001 50.9  9.1 51.5  11.3 .65
.001 11.7 12.5 .84




.42 14.0 14.2 .96
.005 23.5 25.0 .78
.069 62.6 60.8 .76
ion functional class; LV, left ventricle; LA, left atrium; TR, tricuspid regurgitation;
er (%) or mean  SD. yValues are given as% or mean  SD.
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(n ¼ 120) P value
Bypass time, min 131.6  38.5 126.6  43.2 .30
Crossclamp time, min 84.3  28.7 80.5  32.0 .39
Maze procedure 44 (24.6) 39 (32.5) .15
Concomitant TAP 23 (12.8) 35 (29.2) .001
Mitral repair procedure
Ring annuloplasty 179 (100) 120 (100)
Quadrangular/triangular
resection
103 (57.5) 71 (59.2) .81
Artificial chordate 60 (33.5) 32 (26.7) .25
Commissuroplasty 33 (18.4) 26 (21.7) .55
Alfieri 8 (4.5) 4 (3.3) .77
Chordal transfer or
shortening
7 (3.9) 5 (4.2) .91
Leaflet plication 3 (1.7) 7 (5.8) .10
Leaflet manipulation
Anterior leaflet 46 (25.7) 41 (34.2) .11
Posterior leaflet 104 (58.1) 68 (56.7) .81
Bileaflet 28 (15.6) 10 (8.3) .063
Values are given as number (%) or mean  SD. TAP, Tricuspid annuloplasty.
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regression analysis, both groups had comparable freedom
from significant MR (>2þ) (HR, 0.81; 95% confidence
interval, 0.31-2.14; P ¼ .67) (Figure 3, right).TABLE 3. Postoperative outcomes’ comparison between the





(n ¼ 120) P value
Early death (<30 d) 0 (0) 0 (0)
Hospital stay, d* 6 (5-8) 9 (7-14) .039
ICU stay, h* 28 (22-47) 47 (30-72) .012
Complications
Reoperations for bleeding 3 (1.7) 4 (3.3) .35
ARF requiring dialysis 1 (0.6) 1 (0.8) .78
Low cardiac output 0 (0) 0 (0)
Stroke 0 (0) 2 (1.7) .084
Permanent pacemaker
insertion
0 (0) 1 (0.8) .22
Thromboembolic event 0 (0) 0 (0)
Reoperations for MR 2 (1.1) 1 (0.8) >.99
Late mortality 4 (2.2) 6 (5) .19
Last echocardiographic data
(>6 mo) (n ¼ 292)y
LV ejection fraction,% 59.3  6.9 58.4  7.4 .35
LV systolic dimension, mm 32.4  5.8 32.7  7.3 .76
LV diastolic dimension, mm 49.9  5.2 50.1  6.6 .82
LA dimension, mm 42.4  5.2 45.1  8.9 .031
TV pressure gradient, mmHg 23.4  6.5 24.5  7.2 .22
Values are given as number (%) or mean  SD. ICU, Intensive care unit; ARF, acute
renal failure;MR, mitral regurgitation; LV, left ventricular; LA, left atrial; TV, tricuspid
valve. *Values are given as the median (interquartile range). yAdjusted with the use of
inverse-probability-of-treatment weighting.
1550 The Journal of Thoracic and Cardiovascular SurDISCUSSION
Since MICS was introduced in the 1990s, its advantages,
such as early postoperative recovery, better respiratory tract
function, better cosmetic results, and less pain and bleeding,
have been widely accepted. Current guidelines predicate
early referral for MV repair in asymptomatic patients on
the ability to offer complete anatomic correction, with
greater than 90% certainty accompanied by low morbidity
and mortality rates.18 Asymptomatic or minimally symp-
tomatic patients may seek to avoid traditional surgical inci-
sions when less invasive options are possible, hoping to
minimize the length of temporary postoperative disability.19
However, there must be the prerequisites for minimally in-
vasive MV repair: completeness of surgical correction,
safety, and good or at least equivalent outcomes compared
with conventional sternotomy.
Although minimally invasiveMV repair has been consid-
ered to be a feasible alternative to the conventional full ster-
notomy approach, with low perioperative morbidity and
mortality and with several studies reporting on acceptable
early and long-term outcomes,2,3,7 its active use is limited
to few centers in South Korea. This may be attributable to
the concerns about the increased operative risk and
complications, the long learning curve, and relatively low
cost-effectiveness as the result of the high price of the
MICS equipment.20 Most important, the major concerns
are related to potential limitations in using the various
MV repair techniques and the competence required for
MV repair with the use of MICS equipment.
To determine whether MICS for MV repair is feasible,
the effectiveness of the MV repair technique itself and the
maintenance of MV function must be assessed throughout
the late period. For this reason, our study focused on the re-
currence of significant MR after surgery, and we observed
no statistical differences in the long-term recurrence rate
of MR between conventional sternotomy and minithoracot-
omy (Figure 3). In support of our results, a recent study also
demonstrated no difference in the proportion of patients
with MR grade 3þ or 4þ at 1 and 5 years after minithora-
cotomy when compared with the sternotomy approach.5 Al-
though there have been several reports comparing the long-
term outcomes between MICS and sternotomy, few studies
demonstrated the long-term quality of the repaired MVand
freedom from significant MR. Raanani and colleagues8 re-
ported late echocardiographic analysis comparing MR re-
pair through the port-access versus the median sternotomy
approach in isolated posterior MV pathology, which re-
vealed 91% versus 82% freedom from moderate or greater
MR at 5 years (P¼ .90). Our data showed a low reoperation
rate for the MV problem (1.1% in the minithoracotomy
group and 0.8% in the sternotomy group) and favorable
freedom from significant MR at 5 years (86.1% vs
85.3%), with no statistical difference between the 2 groupsgery c May 2014
FIGURE 2. Freedom from major event or death. HR, Hazard ratio; CI, confidence interval.
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study indicated that there was a relatively greater portion
of anterior MV pathology in the patient population
(33.5% in the minithoracotomy group and 44.2% in the
sternotomy group), and the various MV repair techniques
were used in the 2 groups without showing any statistical
difference (Table 2).
Another advantage of the thoracotomy approach for
MV surgery is better MV exposure. A right lateral mini-
thoracotomy for MV exposure allows a direct view of
the posteriorly positioned MV, including the valvular
and subvalvular apparatus, without a significant amount
of tissue dissection or distortion of the heart.21 Even
when an implanted AV exists, the MV approach and ma-
nipulation are easier with a thoracotomy approach without
removal of the prosthetic AV. Minimally invasive MV re-
operation is also a useful alternative for patients requiring
a MV procedure after a previous cardiac operation.21 Car-
diac reoperation for MV generally has a higher risk of
morbidity and mortality than the first operation, particu-
larly for the MV anatomic position.22 A sternotomy
approach with extensive pericardial adhesions carries
a higher risk of major vessel injury and the danger of in-
juring a previous patent coronary artery bypass graft. TheFIGURE 3. Freedom from moderate or greater mitral regurg
The Journal of Thoracic and Carthoracotomy approach can give excellent exposure of the
MV, good myocardial protection, and decreased risk of
major vascular injury, resulting in less perioperative
bleeding, lower transfusion requirements, and lower oper-
ative mortality.23,24 Recent studies have reported that
MICS is cost-effective because of reduced bleeding and
shorter ICU and hospital stays.25,26Study Limitations
This study is subject to the limitations inherent to retro-
spective observational data studies, and the study popula-
tion is relatively small compared with that of the
international data. As previously mentioned, the small num-
bers were mainly due to the fact that port-access minimally
invasive MV surgery is still limited to only several centers
in Korea.CONCLUSIONS
In conclusion, a minithoracotomy approach for MV re-
pair showed comparable clinical and echocardiographic
outcomes to the conventional sternotomy approach. Fur-
thermore, minimally invasive MV repair is efficacious and
feasible.itation (MR). HR, Hazard ratio; CI, confidence interval.
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